HCSC closed a $3.3 billion acquisition of Cigna's Medicare business in March 2025, with 71% of its MA enrollment now in HealthSpring rather than in the legacy Blues plans
Key Takeaways Retatrutide is being studied as a triple agonist that targets GIP, GLP-1, and glucagon receptors
Some are positioned as if they can replace skincare, procedures, sleep, or diet quality
"Does Aetna cover Wegovy, Ozempic, Mounjaro & Wegovy?" Ro Health
The FDA classification of retatrutide has raised regulatory discussion as the compound has 39 alpha amino acids in its main chain, just below the 40 amino acid threshold used to distinguish between peptides and proteins
Lund ML, Sorrentino G, Egerod KL, Kroone C, Mortensen B, Knop FK, et al